According to TechSci Research report, “Remote Access Management Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F, The Global Remote Access Management Market was valued at USD 21.37 billion in 2024 and is expected to reach USD 48.84 billion by 2030 with a CAGR of 14.77% through 2030.
Request For Sample Copy of Report For More Detailed Market insight: https://www.techsciresearch.com/sample-report.aspx?cid=27154#requestform
As cyber threats become increasingly sophisticated and frequent, organizations are forced to reassess how they manage and secure remote access to their networks. The increasing number of data breaches, ransomware attacks, and advanced persistent threats has made security a top priority for businesses across the globe. These security threats often exploit weaknesses in traditional access controls, making Remote Access Management an essential tool for minimizing vulnerabilities. The growing reliance on cloud services and the use of personal devices for work-related activities (through Bring Your Own Device policies) further expose organizations to potential security risks. Remote Access Management solutions provide enhanced security features, including multi-factor authentication, end-to-end encryption, and advanced monitoring capabilities, which help businesses safeguard their networks from unauthorized access. These solutions also incorporate user behavior analytics, which enable organizations to detect and respond to unusual access patterns that may indicate a potential security breach.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on the "Global Remote Access Management Market"@https://www.techsciresearch.com/report/remote-access-management-market/27154.html
Market Drivers
Market Trends
The shift toward cloud-based Remote Access Management solutions is accelerating as more businesses adopt cloud infrastructure to support remote work and digital transformation. Traditional on-premises solutions often require significant hardware investments and are less flexible when it comes to scaling up or adjusting to new business needs. In contrast, cloud-based solutions offer numerous advantages, including cost efficiency, scalability, and ease of deployment. Cloud-based Remote Access Management allows businesses to manage access to corporate resources and data from anywhere, at any time, with a focus on securing remote endpoints. These solutions often come with built-in features such as real-time monitoring, automated updates, and the ability to integrate with other cloud services, making them more adaptable to the evolving needs of modern businesses. Cloud platforms often leverage advanced security technologies, such as encryption and multi-factor authentication, which further enhance the security of remote access. As businesses increasingly move their infrastructure to the cloud, the demand for cloud-based Remote Access Management solutions is expected to rise. This trend reflects the broader shift in enterprise IT strategy, where businesses prioritize agility, flexibility, and cost-effectiveness in their operations. The continued growth of cloud adoption will play a crucial role in the expansion of the Remote Access Management market.
- Key market players in the Remote Access Management Market are: -
- Cisco Systems, Inc.
- Fortinet, Inc.
- Microsoft Corporation
- Palo Alto Networks, Inc.
- Check Point Software Technologies Ltd.
- Zscaler, Inc.
- WatchGuard Technologies, Inc.
- BeyondTrust Corporation
- Broadcom, Inc.
- Cloudflare, Inc.
Customers can also request for 10% free customization on this report.
“The Remote Access Management market is expected to grow significantly in the future, driven by the increasing adoption of remote and hybrid work models, heightened cybersecurity concerns, and the rapid shift towards cloud-based infrastructures. As businesses prioritize secure access to corporate resources, demand for advanced solutions offering encryption, multi-factor authentication, and seamless endpoint management will rise. The growing reliance on mobile devices and the expansion of small and medium-sized enterprises will further fuel market growth. Integration of Artificial Intelligence and Machine Learning in Remote Access Management systems for enhanced threat detection and automation will also play a key role in shaping the market's future.” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.
Market Opportunities
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Website: https://www.techsciresearch.com
Market Scenario:Remote access is the ability to get access to a particular network or a computer from a remote distance.
Technical advancement and growing cellular network capability has enabled people to save time and access information in quick time through remote access management.Major forces driving the growth of remote access management market are the increasing employee strength globally and the flexibility it provides to work from anywhere and at any time.
In IPsec VPN, a virtual private network client is installed on the end user’s computer and is configured with details about the target network, like IP address.
Every time the user wants to connect to the remote network, they start the virtual private network client and a secure connection to the corporate firewall is established.The global remote access management market is expected to grow at approx.
USD 47 Billion by 2023, at 11% of CAGR between 2017 and 2023.Get Sample of Report @ https://www.marketresearchfuture.com/sample_request/3217Key PlayersThe prominent players in remote access management market are – Cisco Systems, Inc. (U.S.), Juniper Networks (U.S.), VMware, Inc. (U.S.), Fortinet (U.S.), Citrix Systems, Inc. (U.S.), Sophos Ltd. (U.K.), Brocade Communication Systems, Inc. (U.S.), Palo Alto Networks, Inc. (U.S.), NetScreen Technologies, Inc. (U.S.) and Symantec Corporation (U.S.) among others.Segments:Remote access management market can be segmented on the basis of following:By ComponentSoftwareSolutionBy TechnologyIPsec VPNSSL VPNDirect AccessBy Organization sizeSME’sLarge EnterprisesBy VerticalBFSIManufacturingHealthcareIT & TelecommunicationAerospace & DefenseGovernmentOthersRegional AnalysisThe regional analysis of remote access management market is being studied for regions such as Asia Pacific, North America, Europe and Rest of the World.
It has been observed that North America is estimated to account for the largest share of the market, whereas Asia-Pacific is projected to grow at the fastest rate during the forecast period.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
